![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
Use your leftovers: answers for excess stock
By Durbin
The size, complexity and geographical distribution of clinical trials can often lead to stock being left over, either at specific sites during the trial or overall following its conclusion. What to do with these pharmaceuticals can be something of a head-scratcher, but Durbin has the experience and know-how necessary to deal with this issue in as efficient and cost-effective manner as possible.
![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)